Century Therapeutics, Inc. (IPSC)

Century Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	55.52	58.44	47.32	84.27	56.45	27.21
Short-Term Investments	77.23	130.85	125.41	231.23	166.43	48.54
Cash & Short-Term Investments	132.75	189.29	172.74	315.5	222.88	75.75
Cash Growth	-32.99%	9.58%	-45.25%	41.56%	194.22%	-7.10%
Other Receivables	0.48	1.52	2.24	0.78	0.25	0.91
Receivables	0.48	1.52	2.24	0.78	0.25	0.91
Prepaid Expenses	4.48	1.53	0.76	1.45	1.61	-
Other Current Assets	-	1.71	1.26	1.99	3.42	2.14
Total Current Assets	137.71	194.05	176.99	319.72	228.15	78.8
Property, Plant & Equipment	70.28	90.85	92.08	111.73	69.82	24.78
Long-Term Investments	-	30.82	89.1	51.85	135.91	1.05
Other Intangible Assets	34.2	34.2	-	-	-	-
Other Long-Term Assets	2.53	3.3	2.52	3.24	3.49	2.15
Total Assets	244.72	353.22	360.69	486.54	437.38	106.78
Accounts Payable	2.62	3.08	2.74	5.45	7.6	8.08
Accrued Expenses	7.28	12.59	8.64	9.37	5.43	3.79
Current Portion of Long-Term Debt	-	-	-	6.5	1.04	-
Current Portion of Leases	3.77	4.87	1.51	0.48	0.62	0.24
Current Unearned Revenue	-	109.16	4.37	7.15	-	-
Other Current Liabilities	8.36	0.08	0.58	0.87	0.98	-
Total Current Liabilities	22.03	129.78	17.85	29.82	15.66	12.11
Long-Term Debt	-	-	-	3.74	8.9	9.64
Long-Term Leases	41.19	48.96	46.66	38.7	14.56	11.68
Long-Term Unearned Revenue	-	-	111.38	110.83	-	-
Long-Term Deferred Tax Liabilities	4.37	4.37	-	-	-	-
Other Long-Term Liabilities	0.78	8.74	0.06	0.72	2.02	-
Total Liabilities	68.37	191.85	175.94	183.81	41.14	33.43
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	949.02	943.37	840.41	824.29	785.05	217.83
Retained Earnings	-772.74	-782.34	-655.77	-519.1	-388.17	-292.34
Comprehensive Income & Other	0.06	0.32	0.11	-2.46	-0.65	-31.9
Total Common Equity	176.35	161.36	184.75	302.74	396.24	-106.41
Shareholders' Equity	176.35	161.36	184.75	302.74	396.24	73.35
Total Liabilities & Equity	244.72	353.22	360.69	486.54	437.38	106.78
Total Debt	44.96	53.83	48.17	49.41	25.12	21.56
Net Cash (Debt)	87.79	135.46	124.57	266.08	197.76	54.2
Net Cash Growth	-38.83%	8.75%	-53.19%	34.55%	264.89%	-33.53%
Net Cash Per Share	1.02	1.72	2.10	4.61	6.11	7.24
Filing Date Shares Outstanding	87.31	86.05	64.82	59.17	58.82	7.84
Total Common Shares Outstanding	86.53	85.84	60.34	58.47	55.01	7.48
Working Capital	115.68	64.27	159.15	289.9	212.5	66.69
Book Value Per Share	2.04	1.88	3.06	5.18	7.20	-14.22
Tangible Book Value	142.15	127.16	184.75	302.74	396.24	-106.41
Tangible Book Value Per Share	1.64	1.48	3.06	5.18	7.20	-14.22
Machinery	34.55	33.61	30.66	30.36	19.47	9.02
Construction In Progress	0.17	0.1	0.12	14	32.84	5.77
Leasehold Improvements	61.65	61.58	60.86	48.95	8.37	1.96

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q